Novel toxic shock syndrome toxin-1 amino acids required for biological activity

Biochemistry

Volumn 47, Issue 49, 2008, Pages 12995-13003

  Brosnahan, Amanda J ^a   Schaefers, Matthew M ^b   Amundson, William H ^a   Mantz, Mary J ^c   Squier, Christopher A ^c   Peterson, Marnie L ^b   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINATION; AMINES; AMINO ACIDS; ANIMAL CELL CULTURE; ORGANIC ACIDS;

ALANINE MUTATIONS; BIOLOGICAL ACTIVITIES; CYTOKINE PRODUCTIONS; EX-VIVO; HUMAN VAGINAL EPITHELIAL CELLS; IMMUNE CELLS; PERMEABILITY MODELS; S. AUREUS; STAPHYLOCOCCUS AUREUS; SUPERANTIGEN; T LYMPHOCYTES; TOXIC SHOCKS; VAGINAL EPITHELIUMS; WILD TYPES;

TOXIC MATERIALS;

ALANINE; AMINO ACID; BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; INTERLEUKIN 8; POLYPEPTIDE; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; IMMUNE RESPONSE; MENSTRUAL CYCLE; MUTATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS; SWINE; T LYMPHOCYTE; TOXIC SHOCK SYNDROME; TOXIN ANALYSIS; VAGINA MUCOSA;

ALANINE; AMINO ACIDS; ANIMALS; BACTERIAL TOXINS; BASE SEQUENCE; BINDING SITES; CELL MEMBRANE PERMEABILITY; CULTURE TECHNIQUES; ENTEROTOXINS; EPITHELIAL CELLS; FEMALE; INJECTIONS, INTRAVENOUS; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MUTATION; PEPTIDES; RABBITS; SHOCK, SEPTIC; SUPERANTIGENS; SWINE; VAGINA;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS; SUS;

EID: 57449111097     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801468w     Document Type: Article

References (49)

1. Bergdoll, M. S., Crass, B. A., Reiser, R. F., Robbins, R. N., and Davis, J. P. (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1, 1017-1021.
2. Schlievert, P. M., Shands, K. N., Dan, B. B., Schmid, G. P., and Nishimura, R. D. (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143, 509-516.
3. Schlievert, P. M. (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1, 1149-1150.
4. Musser, J. M., Hauser, A. R., Kim, M. H., Schlievert, P. M., Nelson, K., and Selander, R. K. (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U.S.A. 88, 2668-2672.
5. Lee, P. K., and Schlievert, P. M. (1989) Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J. Clin. Microbiol. 27, 1890-1892.
6. Schlievert, P. M., Assimacopoulos, A. P., and Cleary, P. P. (1996) Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J. Lab Clin. Med. 127, 13-22.
7. Talkington, D. F., Schwartz, B., Black, C. M., Todd, J. K., Elliott, J., Breiman, R. F., and Facklam, R. R. (1993) Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61, 3369-3374.
8. Hauser, A. R., Stevens, D. L., Kaplan, E. L., and Schlievert, P. M. (1991) Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J. Clin. Microbiol. 29, 1562-1567.
9. Schlievert, P. M., Tripp, T. J., and Peterson, M. L. (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 42, 2875-2876.
10. Marrack, P., and Kappler, J. (1990) The staphylococcal enterotoxins and their relatives. Science 248, 1066.
11. Choi, Y., Lafferty, J. A., Clements, J. R., Todd, J. K., Gelfand, E. W., Kappler, J., Marrack, P., and Kotzin, B. L. (1990) Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172, 981-984.
12. Fraser, J. D. (1989) High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. 339 221-223.
13. Scholl, P., Diez, A., and Geha, R. (1989) Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J. Immunol. 143, 2583-2588.
14. White, J., Herman, A., Pullen, A. M., Kubo, R., Kappler, J. W., and Marrack, P. (1989) The V[beta]-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35.
15. Callahan, J. E., Herman, A., Kappler, J. W., and Marrack, P. (1990) Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J. Immunol. 144, 2473-2479.
16. Schlievert, P. M., Bettin, K. M., and Watson, D. W. (1978) Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proc. Soc. Exp. Biol. Med. 157, 472-475.
17. Dinges, M. M., and Schlievert, P. M. (2001) Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect. Immun. 69, 7169-7172.
18. Dinges, M. M., Jessurun, J., and Schlievert., P. M. (1998) Comparisons of mouse and rabbit models of toxic shock syndrome. Int. Congr. Symp. Ser. 229, 167-168.
19. Schlievert, P. M., Bettin, K. M., and Watson, D. W. (1979) Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect. Immun. 26, 467-472.
20. Schlievert, P. M., and Watson, D. W. (1979) Biogenic amine involvement in pyrogenicity and enhancement of lethal endotoxin shock by group A streptococcal pyrogenic exotoxin. Proc. Soc. Exp. Biol. Med. 162, 269-274.
21. Kotzin, B. L., Leung, D. Y., Kappler, J., and Marrack, P. (1993) Superantigens and their potential role in human disease. Adv. Immunol. 54, 99-166.
22. Davis, C. C., Kremer, M. J., Schlievert, P. M., and Squier, C. A. (2003) Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189, 1785-1791.
23. van der Bijl, P., Thompson, I. O., and Squier, C. A. (1997) Comparative permeability of human vaginal and buccal mucosa to water. Eur. J. Oral. Sci. 105, 571-575.
24. Squier, C. A., Mantz, M. J., Schlievert, P. M., and Davis, C. C. (2008) Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci. 97, 9-21.
25. Law, S., Wertz, P. W., Swartzendruber, D. C., and Squier, C. A. (1995) Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch. Oral Biol. 40, 1085-1091.
26. Wertz, P. W., and van den Bergh, B. (1998) The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 91, 85-96.
27. Peterson, M. L., Ault, K., Kremer, M. J., Klingelhutz, A. J̇, Davis, C. C., Squier, C. A., and Schlievert, P. M. (2005) The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun. 73, 2164-2174.
28. Shupp, J. W., Jett, M., and Pontzer, C. H. (2002) Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun. 70, 2178-2186.
29. Wang, B., Schlievert, P. M., Gaber, A. O., and Kotb, M. (1993) Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J. Immunol. 151, 1419-1429.
30. Kim, J., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266, 1870-1874.
31. McCormick, J. K., Tripp, T. J., Llera, A. S., Sundberg, E. J., Dinges, M. M., Mariuzza, R. A., and Schlievert, P. M. (2003) Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. J. Immunol. 171, 1385-1392.
32. Hoffmann, M. L., Jablonski, L. M., Crum, K. K., Hackett, S. P., Chi, Y. I., Stauffacher, C. V., Stevens, D. L., and Bohach, G. A. (1994) Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect. Immun. 62, 3396-3407.
33. Arad, G., Levy, R., Hillman, D., and Kaempfer, R. (2000) Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. 6, 414-421.
34. Arad, G., Hillman, D., Levy, R., and Kaempfer, R. (2001) Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J. Leukocyte Biol. 69, 921-927.
35. Arad, G., Levy, R., and Kaempfer, R. (2002) Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigen. Immunol. Lett. 82, 75-78.
36. Arad, G., Hillman, D., Levy, R., and Kaempfer, R. (2004) Broadspectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Immunol. Lett. 91, 141-145.
37. Rajagopalan, G., Sen, M. M., and David, C. S. (2004) In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Infect. Immun. 72, 6733-6737.
38. Earhart, C. A., Mitchell, D. T., Murray, D. L., Pinheiro, D. M., Matsumura, M., Schlievert, P. M., and Ohlendorf, D. H. (1998) Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity. Biochemistry 37, 7194-7202.
39. Schlievert, P. M. (1988) Immunochemical Assays for Toxic Shock Syndrome Toxin-1. Methods Enzymol. 165, 339-344.
40. Halbert, C. L., Demers, G. W., and Galloway, D. A. (1992) The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66, 2125-2134.
41. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
42. Fichorova, R., Rheinwald, J., and Anderson, D. (1997) Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins 10.1095/biolreprod57.4.847. Biol. Reprod. 57, 847-855.
43. Fichorova, R. N., and Anderson, D. J. (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol. Reprod. 60, 508-514.
44. Poindexter, N. J., and Schlievert, P. M. (1985) Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J. Infect. Dis. 151, 65-72.
45. Kim, Y. B., and Watson, D. W. (1970) A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock. J. Exp. Med. 131, 611-622.
46. Schlievert, P. M. (1982) Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 36, 123-128.
47. Schlievert, P. M., Jablonski, L. M., Roggiani, M., Sadler, I., Callantine, S., Mitchell, D. T., Ohlendorf, D. H., and Bohach, G. A. (2000) Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect. Immun. 68, 3630-3634.
48. Moza, B., Varma, A. K., Buonpane, R. A., Zhu, P., Herfst, C. A., Nicholson, M. J., Wilbuer, A. K., Seth, N. P., Wucherpfennig, K. W., McCormick, J. K., Kranz, D. M., and Sundberg, E. J. (2007) Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J. 26, 1187-1197.
49. Murray, D. L., Earhart, C. A., Mitchell, D. T., Ohlendorf, D. H., Novick, R. P., and Schlievert, P. M. (1996) Localization of biologically important regions on toxic shock syndrome toxin 1. Infect. Immun. 64, 371-374.